By "Heart-on-a-chip" technology - simulating the human heart on an engineering chip and using microelectrodes to measure the effects of compound exposure, it is possible to ensure that potential life-saving new drugs are safe and effective, while reducing the need for humans and animal testing.
Market Analysis and Insights: Global Heart-on-a-chip Market
The global Heart-on-a-chip market size is projected to reach US$ XX million by 2027, from US$ XX million in 2019, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Heart-on-a-chip market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Heart-on-a-chip market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Heart-on-a-chip market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Heart-on-a-chip market.
Heart-on-a-chip Breakdown Data by Type
Children Heart-on-a-chip
Adult Heart-on-a-chip
Heart-on-a-chip Breakdown Data by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
Based on regional and country-level analysis, the Heart-on-a-chip market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Heart-on-a-chip market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Tara Biosystems
Market Analysis and Insights: Global Heart-on-a-chip Market
The global Heart-on-a-chip market size is projected to reach US$ XX million by 2027, from US$ XX million in 2019, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Heart-on-a-chip market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Heart-on-a-chip market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Heart-on-a-chip market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Heart-on-a-chip market.
Heart-on-a-chip Breakdown Data by Type
Children Heart-on-a-chip
Adult Heart-on-a-chip
Heart-on-a-chip Breakdown Data by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users
Based on regional and country-level analysis, the Heart-on-a-chip market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Heart-on-a-chip market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory
Micronit Microtechnologies B.V.
Tara Biosystems
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Heart-on-a-chip Market Size Growth Rate by Type (2021-2027)
1.2.2 Children Heart-on-a-chip
1.2.3 Adult Heart-on-a-chip
1.3 Market by Application
1.3.1 Global Heart-on-a-chip Market Share by Application (2021-2027)
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heart-on-a-chip Market Size
2.2 Heart-on-a-chip Market Size by Regions
2.2.1 Heart-on-a-chip Growth Rate by Regions (2021-2027)
2.2.2 Heart-on-a-chip Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Heart-on-a-chip Revenue by Players (2020-2021)
3.2 Heart-on-a-chip Key Players Headquaters and Area Served
3.3 Key Players Heart-on-a-chip Product/Solution/Service
3.4 Date of Enter into Heart-on-a-chip Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Heart-on-a-chip Market Size by Type (2021-2027)
4.2 Global Heart-on-a-chip Market Size by Application (2021-2027)
5 North America
5.1 North America Heart-on-a-chip Market Forecast (2021-2027)
5.2 Heart-on-a-chip Key Players in North America
5.3 North America Heart-on-a-chip Market Size by Type
5.4 North America Heart-on-a-chip Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Heart-on-a-chip Market Forecast (2021-2027)
6.2 Heart-on-a-chip Key Players in Europe
6.3 Europe Heart-on-a-chip Market Size by Type
6.4 Europe Heart-on-a-chip Market Size by Application
7 Japan
7.1 Japan Heart-on-a-chip Market Forecast (2021-2027)
7.2 Heart-on-a-chip Key Players in Europe
7.3 Japan Heart-on-a-chip Market Size by Type
7.4 Japan Heart-on-a-chip Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Heart-on-a-chip Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Heart-on-a-chip Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Heart-on-a-chip Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Emulate
9.1.1 Emulate Company Details
9.1.2 Emulate Description and Business Overview
9.1.3 Emulate Heart-on-a-chip Introduction
9.1.4 Emulate Revenue in Heart-on-a-chip Business (2020-2021)
9.1.5 Emulate Recent Development
9.2 Tissuse
9.2.1 Tissuse Company Details
9.2.2 Tissuse Description and Business Overview
9.2.3 Tissuse Heart-on-a-chip Introduction
9.2.4 Tissuse Revenue in Heart-on-a-chip Business (2020-2021)
9.2.5 Tissuse Recent Development
9.3 Hesperos
9.3.1 Hesperos Company Details
9.3.2 Hesperos Description and Business Overview
9.3.3 Hesperos Heart-on-a-chip Introduction
9.3.4 Hesperos Revenue in Heart-on-a-chip Business (2020-2021)
9.3.5 Hesperos Recent Development
9.4 CN Bio Innovations
9.4.1 CN Bio Innovations Company Details
9.4.2 CN Bio Innovations Description and Business Overview
9.4.3 CN Bio Innovations Heart-on-a-chip Introduction
9.4.4 CN Bio Innovations Revenue in Heart-on-a-chip Business (2020-2021)
9.4.5 CN Bio Innovations Recent Development
9.5 Draper Laboratory
9.5.1 Draper Laboratory Company Details
9.5.2 Draper Laboratory Description and Business Overview
9.5.3 Draper Laboratory Heart-on-a-chip Introduction
9.5.4 Draper Laboratory Revenue in Heart-on-a-chip Business (2020-2021)
9.5.5 Draper Laboratory Recent Development
9.6 Mimetas
9.6.1 Mimetas Company Details
9.6.2 Mimetas Description and Business Overview
9.6.3 Mimetas Heart-on-a-chip Introduction
9.6.4 Mimetas Revenue in Heart-on-a-chip Business (2020-2021)
9.6.5 Mimetas Recent Development
9.7 Nortis
9.7.1 Nortis Company Details
9.7.2 Nortis Description and Business Overview
9.7.3 Nortis Heart-on-a-chip Introduction
9.7.4 Nortis Revenue in Heart-on-a-chip Business (2020-2021)
9.7.5 Nortis Recent Development
9.8 Kirkstall
9.8.1 Kirkstall Company Details
9.8.2 Kirkstall Description and Business Overview
9.8.3 Kirkstall Heart-on-a-chip Introduction
9.8.4 Kirkstall Revenue in Heart-on-a-chip Business (2020-2021)
9.8.5 Kirkstall Recent Development
9.9 Cherry Biotech SAS
9.9.1 Cherry Biotech SAS Company Details
9.9.2 Cherry Biotech SAS Description and Business Overview
9.9.3 Cherry Biotech SAS Heart-on-a-chip Introduction
9.9.4 Cherry Biotech SAS Revenue in Heart-on-a-chip Business (2020-2021)
9.9.5 Cherry Biotech SAS Recent Development
9.10 Else Else Kooi Laboratory
9.10.1 Else Else Kooi Laboratory Company Details
9.10.2 Else Else Kooi Laboratory Description and Business Overview
9.10.3 Else Else Kooi Laboratory Heart-on-a-chip Introduction
9.10.4 Else Else Kooi Laboratory Revenue in Heart-on-a-chip Business (2020-2021)
9.10.5 Else Else Kooi Laboratory Recent Development
9.11 Micronit Microtechnologies B.V.
9.11.1 Micronit Microtechnologies B.V. Company Details
9.11.2 Micronit Microtechnologies B.V. Description and Business Overview
9.11.3 Micronit Microtechnologies B.V. Heart-on-a-chip Introduction
9.11.4 Micronit Microtechnologies B.V. Revenue in Heart-on-a-chip Business (2020-2021)
9.11.5 Micronit Microtechnologies B.V. Recent Development
9.12 Tara Biosystems
9.12.1 Tara Biosystems Company Details
9.12.2 Tara Biosystems Description and Business Overview
9.12.3 Tara Biosystems Heart-on-a-chip Introduction
9.12.4 Tara Biosystems Revenue in Heart-on-a-chip Business (2020-2021)
9.12.5 Tara Biosystems Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Heart-on-a-chip Market Size Growth Rate by Type (2021-2027)
1.2.2 Children Heart-on-a-chip
1.2.3 Adult Heart-on-a-chip
1.3 Market by Application
1.3.1 Global Heart-on-a-chip Market Share by Application (2021-2027)
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heart-on-a-chip Market Size
2.2 Heart-on-a-chip Market Size by Regions
2.2.1 Heart-on-a-chip Growth Rate by Regions (2021-2027)
2.2.2 Heart-on-a-chip Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Heart-on-a-chip Revenue by Players (2020-2021)
3.2 Heart-on-a-chip Key Players Headquaters and Area Served
3.3 Key Players Heart-on-a-chip Product/Solution/Service
3.4 Date of Enter into Heart-on-a-chip Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Heart-on-a-chip Market Size by Type (2021-2027)
4.2 Global Heart-on-a-chip Market Size by Application (2021-2027)
5 North America
5.1 North America Heart-on-a-chip Market Forecast (2021-2027)
5.2 Heart-on-a-chip Key Players in North America
5.3 North America Heart-on-a-chip Market Size by Type
5.4 North America Heart-on-a-chip Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Heart-on-a-chip Market Forecast (2021-2027)
6.2 Heart-on-a-chip Key Players in Europe
6.3 Europe Heart-on-a-chip Market Size by Type
6.4 Europe Heart-on-a-chip Market Size by Application
7 Japan
7.1 Japan Heart-on-a-chip Market Forecast (2021-2027)
7.2 Heart-on-a-chip Key Players in Europe
7.3 Japan Heart-on-a-chip Market Size by Type
7.4 Japan Heart-on-a-chip Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Heart-on-a-chip Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Heart-on-a-chip Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Heart-on-a-chip Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Emulate
9.1.1 Emulate Company Details
9.1.2 Emulate Description and Business Overview
9.1.3 Emulate Heart-on-a-chip Introduction
9.1.4 Emulate Revenue in Heart-on-a-chip Business (2020-2021)
9.1.5 Emulate Recent Development
9.2 Tissuse
9.2.1 Tissuse Company Details
9.2.2 Tissuse Description and Business Overview
9.2.3 Tissuse Heart-on-a-chip Introduction
9.2.4 Tissuse Revenue in Heart-on-a-chip Business (2020-2021)
9.2.5 Tissuse Recent Development
9.3 Hesperos
9.3.1 Hesperos Company Details
9.3.2 Hesperos Description and Business Overview
9.3.3 Hesperos Heart-on-a-chip Introduction
9.3.4 Hesperos Revenue in Heart-on-a-chip Business (2020-2021)
9.3.5 Hesperos Recent Development
9.4 CN Bio Innovations
9.4.1 CN Bio Innovations Company Details
9.4.2 CN Bio Innovations Description and Business Overview
9.4.3 CN Bio Innovations Heart-on-a-chip Introduction
9.4.4 CN Bio Innovations Revenue in Heart-on-a-chip Business (2020-2021)
9.4.5 CN Bio Innovations Recent Development
9.5 Draper Laboratory
9.5.1 Draper Laboratory Company Details
9.5.2 Draper Laboratory Description and Business Overview
9.5.3 Draper Laboratory Heart-on-a-chip Introduction
9.5.4 Draper Laboratory Revenue in Heart-on-a-chip Business (2020-2021)
9.5.5 Draper Laboratory Recent Development
9.6 Mimetas
9.6.1 Mimetas Company Details
9.6.2 Mimetas Description and Business Overview
9.6.3 Mimetas Heart-on-a-chip Introduction
9.6.4 Mimetas Revenue in Heart-on-a-chip Business (2020-2021)
9.6.5 Mimetas Recent Development
9.7 Nortis
9.7.1 Nortis Company Details
9.7.2 Nortis Description and Business Overview
9.7.3 Nortis Heart-on-a-chip Introduction
9.7.4 Nortis Revenue in Heart-on-a-chip Business (2020-2021)
9.7.5 Nortis Recent Development
9.8 Kirkstall
9.8.1 Kirkstall Company Details
9.8.2 Kirkstall Description and Business Overview
9.8.3 Kirkstall Heart-on-a-chip Introduction
9.8.4 Kirkstall Revenue in Heart-on-a-chip Business (2020-2021)
9.8.5 Kirkstall Recent Development
9.9 Cherry Biotech SAS
9.9.1 Cherry Biotech SAS Company Details
9.9.2 Cherry Biotech SAS Description and Business Overview
9.9.3 Cherry Biotech SAS Heart-on-a-chip Introduction
9.9.4 Cherry Biotech SAS Revenue in Heart-on-a-chip Business (2020-2021)
9.9.5 Cherry Biotech SAS Recent Development
9.10 Else Else Kooi Laboratory
9.10.1 Else Else Kooi Laboratory Company Details
9.10.2 Else Else Kooi Laboratory Description and Business Overview
9.10.3 Else Else Kooi Laboratory Heart-on-a-chip Introduction
9.10.4 Else Else Kooi Laboratory Revenue in Heart-on-a-chip Business (2020-2021)
9.10.5 Else Else Kooi Laboratory Recent Development
9.11 Micronit Microtechnologies B.V.
9.11.1 Micronit Microtechnologies B.V. Company Details
9.11.2 Micronit Microtechnologies B.V. Description and Business Overview
9.11.3 Micronit Microtechnologies B.V. Heart-on-a-chip Introduction
9.11.4 Micronit Microtechnologies B.V. Revenue in Heart-on-a-chip Business (2020-2021)
9.11.5 Micronit Microtechnologies B.V. Recent Development
9.12 Tara Biosystems
9.12.1 Tara Biosystems Company Details
9.12.2 Tara Biosystems Description and Business Overview
9.12.3 Tara Biosystems Heart-on-a-chip Introduction
9.12.4 Tara Biosystems Revenue in Heart-on-a-chip Business (2020-2021)
9.12.5 Tara Biosystems Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
